Chiesi Slovakia
Pharmaceutical company marketing respiratory, neonatal and rare-disease medicines in Slovakia
Highlights
- ProfitableFY2025 net profit €186k · RÚZ
About Chiesi Slovakia
Chiesi Slovakia s.r.o. is the Slovak affiliate of the Chiesi group. Its website lists prescription medicines grouped under therapeutic areas including respiratory diseases, neonatology, rare diseases, transplantation and other areas, with outpatient and hospital care as product categories. Product information is referred to the State Institute for Drug Control (SÚKL) and the company's medicine labelling.
The company's customers are patients and healthcare settings, and the website describes its products as used in ambulatory and hospital care. Revenue comes from the sale of medicines in Slovakia. The website also lists pharmacovigilance, medical questions and a SpeakUp&BeHeard reporting channel.
The company was founded in 2003 and is registered in Bratislava, at Kovová 24, with a contact line and office e-mail on its website. It is part of Chiesi Pharmaceuticals GmbH in Vienna and the private Chiesi Farmaceutici S.p.A. group in Italy, and it runs a joint management team with the Czech affiliate Chiesi CZ. The careers page links to open positions at Chiesi Slovakia and describes the company as a certified B Corp.
Product: Prescription medicines for respiratory, neonatal, rare, transplant and other therapeutic areas, distributed in Slovakia.
Financials
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | €3.4M | €3.0M | €2.7M | €2.6M | €1.9M |
| Growth | +16% | +9% | +5% | +34% | — |
| EBITDA | €353k | €253k | €186k | €149k | €126k |
| Operating profit | €297k | €210k | €158k | €133k | €108k |
| Net profit | €186k | €133k | €88k | €61k | €67k |
| Net margin | 5.4% | 4.5% | 3.3% | 2.4% | 3.5% |
| Personnel costs | €1.5M | €1.4M | €1.2M | €1.1M | €842k |
| Total assets | €1.2M | €972k | €815k | €742k | €826k |
| Cash | €353k | €280k | €280k | €261k | €494k |
| Liabilities | €448k | €447k | €423k | €438k | €283k |
| Equity | €711k | €525k | €392k | €304k | €543k |
As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.
Jobs at Chiesi Slovakia
Leadership
- Claudia Höller · General Manager Czech Republic & SlovakiaSource: business register
- Alan Undus · Head of Customer Engagement & Business Knowledge, Czech Republic & SlovakiaSource: company website
More biotech & pharma companies
Europa Pharmaceutical
Generic medicines and vaccine solutions for healthcare providers and distributorsNew on EvolcEWOPHARMA
Pharmaceutical marketing, distribution and product portfolio services for healthcare partners across Central and Eastern EuropeProfitableGeneTiCA
Genomics instruments, reagents and analysis solutions for research and clinical laboratories in Central EuropeProfitableGrowingNew on EvolcGENETON
Paternity and genetic testing, bioinformatics analyses and NGS-based clinical diagnostics for clients in SlovakiaGensity
DNA species identification and eDNA biodiversity analysis for environmental monitoring in SlovakiaYoung companyProfitableGrowingGlycanostics
Blood-based glycan test for early prostate cancer detection, aimed at reducing unnecessary biopsies for men
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- OneTrust
- PHP
- jQuery
- nginx